This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders Europe
Save the dates 5-6 March 2025
Congress Center BaselBasel, Switzerland

NanoVation Therapeutics


NanoVation Therapeutics™ (NTx) develops customized nucleic acid and lipid nanoparticle technologies to empower its partners’ genetic medicines. By enabling the safe and efficacious delivery of nucleic acids to a variety of tissues, NTx’s unique toolbox can rapidly advance therapeutic concepts into clinical reality. NTx is delivering tomorrow's genetic medicines, TODAY™.

We're bringing you

  • Next-generation LNP technologies for enabling highly effective immunotherapies and vaccines